China's mRNA Covid-19 vaccine may start late-stage trial in May

China's mRNA Covid-19 vaccine may start late-stage trial in May ARCoV, the China-developed mRNA vaccine candidate that is furthest along the clinical trial process, may get overseas approval to conduct Phase III clinical trial by as early as end-April, China National Radio said in an article on its website. https://ift.tt/eA8V8J